<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110132</url>
  </required_header>
  <id_info>
    <org_study_id>16/70-8/2/2017</org_study_id>
    <nct_id>NCT04110132</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery</brief_title>
  <official_title>Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alexandria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alexandria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the ganglion Impar block in the prevention of
      postoperative pain after anal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative analgesia using ganglion Impar block after anal surgery

      Introduction

      Ganglion Impar block may be used for treatment of chronic perineal pain (1) Aim

      The aim of this study is to evaluate the ganglion Impar block in the prevention of
      postoperative pain after anal surgery.

      Patients and Methods

      After approval of local ethical committee and patient consent, this double blinded randomized
      study will be done on 60 patients undergoing hemorrhoidectomy surgery in Alexandria
      University hospital.

      After standard general anesthesia with Propofol 1-2mg/kg LMA for airway management and
      maintenance with Isoflurane 1%. The patient will be randomized into two groups.

      Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using
      Bupivacaine 0.5% 10ml.

      Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal
      Saline 10ml Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12
      hours postoperative.

      First request of pain medications will be measured.

      Results Results will be collected in tables and graphs. Appropriate statistical analysis will
      be done.

      Discussion Results of the study will be discussed compared to other studies.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>After approval of local ethical committee and patient consent, this double blinded randomized study will be done on 60 patients undergoing hemorrhoidectomy surgery in Alexandria University hospital.
After standard general anesthesia with Propofol 1-2mg/kg LMA for airway management and maintenance with Isoflurane 1%. The patient will be randomized into two groups.
Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml.
Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Participant, care provider and outcomes assessors will not be aware of the used intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>VAS sore 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First request of pain medications will be measured.</measure>
    <time_frame>24 hours</time_frame>
    <description>Time in hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ganglion impar block with Bupivacaine.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml.
Patient will have hemorrhoidectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ganglion impar block with Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml Patient will have hemorrhoidectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ganglion impar block with Bupivacaine.</intervention_name>
    <description>Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml.
Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.</description>
    <arm_group_label>Ganglion impar block with Bupivacaine.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ganglion impar block with normal saline</intervention_name>
    <description>Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.</description>
    <arm_group_label>Ganglion impar block with Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing hemorrhoidectomy surgery in Alexandria University hospital.

        Exclusion Criteria:

          -  Coagulation effects

          -  Allergy to Bupivacaine

          -  Previous anal surgery

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alexandria Faculty of Medicine</name>
      <address>
        <city>Alexandria</city>
        <zip>21111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Mohammad Hazem I Ahmad Sabry, MB,ChB MD</last_name>
      <phone>+2034842236</phone>
      <email>mohammad_hazem@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Cardaillac C, Ploteau S, Labat JJ, Levesque A, Riant T. [Interest of infiltration of Impar node in rebel vulvodynia: About a series of 8 cases]. Prog Urol. 2016 Dec;26(17):1213-1221. doi: 10.1016/j.purol.2016.08.004. Epub 2016 Sep 7. French.</citation>
    <PMID>27614384</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 5, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alexandria</investigator_affiliation>
    <investigator_full_name>Mohammad Hazem I. Ahmad Sabry</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

